<报名开启>, 精彩不容错过！即刻注册参加“强生创新制药免疫研发合作论坛”与强生创新制药免疫专家面对面

Swipe Left For English

免疫系统功能领域的新发现正推动免疫介导性疾病治疗方法的进步。尽管当前药物已使数百万人受益，但仍有许多患者缺乏有效治疗手段。目前，针对免疫性疾病的新型疗法正在研发中，这些疗法旨在恢复机体内部平衡，而非单纯抑制免疫系统。

诚邀您于10月15日（星期二）莅临JLABS @ 上海，与强生全球及亚太研发负责人以及行业和医疗领军人物进行深度对话。我们将共同探讨如何通过合作加速亚太地区免疫学下一代疗法和平台研发。

Jason Witherington

强生创新制药免疫科学创新全球负责人

孙思泉

强生创新制药免疫科学高级总监

Jennifer Bell

强生创新制药免疫科学执行总监

陈清泉

强生创新制药临床与发展免疫学总监

Dan Wang 王丹

强生创新亚太区负责人

Ajay Gautam

强生创新亚太区早期创新合作副总裁

Sophie Shen

JLABS @ 上海负责人

王清音

强生创新亚太区早期创新合作免疫高级总监&中国区域负责人

活动日程：

JLABS @ 上海负责人Sophie Shen致欢迎辞

强生创新亚太区负责人王丹发表开幕演讲

强生创新制药免疫科学创新全球负责人Jason Witherington强生创新制药免疫学发展及重点主题演讲

小组讨论：深入探讨新突破-免疫学领域的机遇在哪里

小组讨论：携手推进自身免疫性疾病治疗领域的合作

一对一合作伙伴洽谈（仅限受邀公司）

其他主要嘉宾：

蔡大庆

夏尔巴投资创始人兼管理合伙人

苏晓迪

礼来亚洲基金执行董事

本次论坛活动大咖云集，将围绕免疫学的重点发展学领域，通过探寻与强生创新潜在的合作机会，力求为患者提供创新和优质的治疗方案，填补当前医疗领域中的空白。

即刻扫码注册，

我们期待与您在 JLABS @ 上海

共商免疫创新合作！

New discoveries in immune system function are driving advancements in treatment for immune-mediated diseases. While current medications have benefited millions, there is still a lack of effective treatment for many others. There are developments of new therapeutics targeting immunological disorders, aiming to restore homeostasis instead of just suppressing the immune system.

Join us onTuesday, 15 Octoberin Shanghai for an engaging dialogue with Johnson & Johnson global & regional experts and other industry and healthcare leaders as we seek to accelerate the next generation of advanced therapies and platforms in immunology in Asia Pacific.

Jason Witherington

Global Head of External Immunology Innovation, J&J London Innovation Centre, Johnson & Johnson

Siquan Sun

Senior Director, Scientific Discovery Immunology, Johnson & Johnson Innovative Medicine

Jennifer Bell

Executive Director, Immunology Scientific Licensing, Business Development, Johnson & Johnson Innovative Medicine

Rick Chen

Director, Senior TA Lead of Immunology China, Johnson & Johnson Innovative Medicine

Dan Wang

Regional Head, Johnson & Johnson Innovation, Asia Pacific

Ajay Gautam

Vice President, Early Innovation Partnering, Johnson & Johnson Innovation, Asia Pacific

Sophie Shen

Head of JLABS @ Shanghai

Qingyin Wang

Senior Director, Early Innovation Partnering, Immunology & China Country Lead, Johnson & Johnson Innovation, Asia Pacific

Agenda:

Welcome Remarks bySophie Shen, Head of JLABS @ Shanghai

Opening Remarks byDan Wang, Regional Head, Johson & Johnson Innovation, Asia Pacific

Presentation on Johnson & Johnson Innovative Medicine Priorities in Immunology,Jason Witherington, Global Head of External Immunology Innovation, J&J London Innovation Centre, Johnson & Johnson

Panel discussion: Gut Check Joint Conversation - Opportunities in Immunology

Panel discussion: Driving collaborative efforts for the treatment of autoimmune diseases

1:1 Partnering Meetings

Other Key Speakers:

Daqing (Darren) Cai

Founder & Managing Partner of Sherpa Healthcare Partners

Xiaodi Su

Principal, Lily Asia Ventures

Our discussion will focus on the development of these cutting-edge technologies to create better therapies for patients and address areas of unmet medical need. This is an excellent opportunity to share your ideas and discover potential collaboration opportunities with Johnson & Johnson Innovation.

Scan the QR code for a detailed agenda

and register now!